STOCKWATCH
·
Healthcare Service Provider
Quarterly Result11 Aug 2025, 08:50 pm

Krsnaa Diagnostics Reports 13% YoY Revenue Growth in Q1FY26; Wins Prestigious Rajasthan Pathology Project

AI Summary

Krsnaa Diagnostics Ltd, a leading diagnostic service provider in India, has reported a 13% year-on-year revenue growth in Q1FY26, reaching INR 21,930 million. The company has also announced that it has been awarded the Rajasthan Pathology project under the National Health Mission (NHM), one of the most transformative healthcare projects in the state. The project involves establishing 42 Mother Labs, 135 Satellite Labs, and over 1,300 Collection Centers across Rajasthan. The project is expected to drive strategic expansion and long-term value creation for the company while making a meaningful difference in public health delivery.

Key Highlights

  • Krsnaa Diagnostics reports 13% YoY revenue growth in Q1FY26
  • Awarded the prestigious Rajasthan Pathology project under NHM
  • To establish 42 Mother Labs, 135 Satellite Labs, and over 1,300 Collection Centers in Rajasthan
  • Project to drive strategic expansion and long-term value creation
  • Expected to make a meaningful difference in public health delivery
KRSNAA
Healthcare Service Provider
Krsnaa Diagnostics Ltd

Price Impact